As a subsidiary of Apotex Inc, Canada's largest independent pharmaceutical company, our goal is to enhance the wellness of the public we serve by advancing the availability of high quality, low cost, safe & effective generic medicines.
Like many NZ businesses, negotiating the challenges of geographical isolation and relatively small scale compared with larger manufacturers and trading partners overseas requires innovative thinking. With healthy doses of 'Kiwi ingenuity' and the support of a strong parent company, Apotex NZ has been successful in saving New Zealand taxpayers millions of dollars by introducing an increasing range of generic medicines.
Our mostly tendered pharmaceutical market environment requires that we accurately forecast and invest to the meet future requirements of the New Zealand public, while staying closely connected to international markets to ensure that our product offerings are timely, relevant and internationally competitive.
Product quality and service excellence are the foundations of our relationship with healthcare providers. Through them, we will continually strive to provide the widest possible access to affordable medicines for all New Zealanders by advancing generics.
New Zealand
